---
type: "Symbol"
title: "Genmab A/S (GMAB.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/GMAB.US/topics.md"
symbol: "GMAB.US"
parent: "https://longbridge.com/en/quote/GMAB.US.md"
count: 13
datetime: "2026-05-07T17:13:27.722Z"
locales:
  - [en](https://longbridge.com/en/quote/GMAB.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GMAB.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GMAB.US/topics.md)
---

# Genmab A/S (GMAB.US) — Community Discussions

### [Nonsense - Pharmaceuticals](https://longbridge.com/en/topics/33934960.md)

- Author: [奇迹的交易员cola](https://longbridge.com/en/profiles/10743314.md)
- Datetime: 2025-09-12T01:05:44.000Z
- Comments: 13
- Benefiting from local R&D demand: $Regeneron Pharma(REGN.US) Logic: Strong in-house R&D engine, focusing on ophthalmology, immunology, and oncology. Its independent innovation capability becom

**Comments:**

- **股海頑童 · 2025-09-30T20:31:59.000Z**: Thanks for sharing!
- **名字什么的都是代号 · 2025-09-12T05:02:34.000Z**: Unit price...
- **济无咎 · 2025-09-12T03:05:20.000Z · 👍 4**: In terms of local R&D, $Vertex Pharma(VRTX.US) has a compelling story to tell, as cystic fibrosis is more prevalent among Caucasians. Other conditions like SLE and IBD, which are also more common among Caucasians, do not yet have a dominant player like VRTX.— Mentioning a smaller company, $Abiva
- *[... 8 more comments →](https://longbridge.com/en/topics/33934960.md)*

### [$Regeneron Pharma(REGN.US)$Genmab A/S(GMAB.US) Pha…](https://longbridge.com/en/topics/33934369.md)

- Author: [奇迹的交易员cola](https://longbridge.com/en/profiles/10743314.md)
- Datetime: 2025-09-12T00:48:43.000Z
- Comments: 10
- $Regeneron Pharma(REGN.US)$Genmab A/S(GMAB.US) Pharmaceuticals are worth watching. Will Trump take action these two weeks? 🤔

**Comments:**

- **财到我家 · 2025-09-12T02:57:30.000Z**: Is Eli Lilly okay?
- **聚宝长桥 · 2025-09-12T01:18:46.000Z · 👍 1**: put it
- **达利欧的交易员 · 2025-09-12T01:08:49.000Z · 👍 1**: Is hands-on bearish for China's innovative drugs?
- *[... 5 more comments →](https://longbridge.com/en/topics/33934369.md)*

### [$Genmab A/S(GMAB.US)At the current stage, the long…](https://longbridge.com/en/topics/31171922.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-06-26T09:14:16.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)At the current stage, the long-short equilibrium point for GMAB is around $19. I hold two positions in GMAB and I'm not panicking yet.

### [$Genmab A/S(GMAB.US)【US Stock Micro Technical Anal…](https://longbridge.com/en/topics/30229515.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-06-01T12:07:41.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)【US Stock Micro Technical Analysis Case: GMAB-Bilibili】https://b23.tv/OSDVwh7

### [$Genmab A/S(GMAB.US)GMAB experienced a brief sidew…](https://longbridge.com/en/topics/30229456.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-06-01T11:50:42.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)GMAB experienced a brief sideways fluctuation and now meets the conditions for a bullish rally (whether it will rally or not is up to it). According to the principle of offset pric

### [GMAB really can't fall any further. It's currently…](https://longbridge.com/en/topics/29682842.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-05-15T08:25:52.000Z
- Comments: 0
- GMAB really can't fall any further. It's currently at the lower edge of the dense trading zone. If it breaks below this edge, the current price will be lower than three offset prices, and the moving a

### [$Genmab A/S(GMAB.US)Woke up, so let's make a trade…](https://longbridge.com/en/topics/29460352.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-05-08T19:51:57.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)Woke up, so let's make a trade.GMAB's potential is nowhere near BeiGene's, the risk-reward ratio isn't great, but still gonna take a shot and face the challenge head-on.Buying now,

### [$Genmab A/S(GMAB.US)This stock is so hard to trade…](https://longbridge.com/en/topics/29178212.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-04-26T09:29:52.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)This stock is so hard to trade, I'll wait until the moving averages realign and show a bullish pattern before making any moves.

### [$Genmab A/S(GMAB.US)【Challenge to 2B Structure: Ta…](https://longbridge.com/en/topics/28414719.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2025-03-27T13:18:46.000Z
- Comments: 0
- $Genmab A/S(GMAB.US)【Challenge to 2B Structure: Taking GMAB stock as an example-Bilibili】https://b23.tv/t9UpetU

### [The interim report performance of GMAB is mediocre…](https://longbridge.com/en/topics/23076266.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2024-08-09T13:44:39.000Z
- Comments: 0
- The interim report performance of GMAB is mediocre, and the micro technical indicators are not in a bullish alignment, so I sold it first.

### [Bought two shares of GMAB, not waiting anymore, ju…](https://longbridge.com/en/topics/22553481.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2024-07-18T13:57:46.000Z
- Comments: 0
- Bought two shares of GMAB, not waiting anymore, just treat it as a fun purchase. Normally, the trend would take a long time, but the earnings will be announced in early August. If the results are good

### [Does anyone know what's going on with GMAB? Its TT…](https://longbridge.com/en/topics/22195772.md)

- Author: [MadFinder](https://longbridge.com/en/profiles/13675217.md)
- Datetime: 2024-07-02T08:12:18.000Z
- Comments: 0
- Does anyone know what's going on with GMAB? Its TTM P/E ratio is normal for a pharmaceutical stock, and its earnings expectations aren't bad either? With ample cash flow, why is it continuously fallin

### [在医药国际市场，制定商业价值的方案有多种选择。其中，最理想的是自主销售产品，但这对于小型制药企业而言…](https://longbridge.com/en/topics/5343257.md)

- Author: [儿子娃娃](https://longbridge.com/en/profiles/7200339.md)
- Datetime: 2023-04-21T05:14:33.000Z
- Comments: 0
- 在医药国际市场，制定商业价值的方案有多种选择。其中，最理想的是自主销售产品，但这对于小型制药企业而言相当具有挑战性。其次，可以与大型制药企业合作，最好的合作方案是按照 55 开的比例对半分成。这种合作模式的价值很大。最后，常见的合作方式是大型制药企业拥有大部分权益，然后将 5~20% 的版税分成给小型制药企业。然而，这种依靠版税分成实现盈利的模式很难实现规模化发展。拿三家制药企业做比较，可以看出自

## References

- [Genmab A/S (GMAB.US)](https://longbridge.com/en/quote/GMAB.US.md)